
### [NCIT:C45249](http://purl.obolibrary.org/obo/NCIT_C45249)
**Label:** Cutaneous Mature B-Cell Neoplasm

**Subclasses:** [NCIT:C45193](http://purl.obolibrary.org/obo/NCIT_C45193) (Primary Cutaneous Diffuse Large B-Cell Lymphoma), [NCIT:C7219](http://purl.obolibrary.org/obo/NCIT_C7219) (Grade 2 Cutaneous Follicular Lymphoma), [NCIT:C6859](http://purl.obolibrary.org/obo/NCIT_C6859) (Grade 3 Cutaneous Follicular Lymphoma), [NCIT:C6858](http://purl.obolibrary.org/obo/NCIT_C6858) (Primary Cutaneous B-Cell Non-Hodgkin Lymphoma), [NCIT:C45194](http://purl.obolibrary.org/obo/NCIT_C45194) (Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C138027](http://purl.obolibrary.org/obo/NCIT_C138027) (Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C138028](http://purl.obolibrary.org/obo/NCIT_C138028) (Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C45163](http://purl.obolibrary.org/obo/NCIT_C45163) (Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C7218](http://purl.obolibrary.org/obo/NCIT_C7218) (Cutaneous Follicular Lymphoma), [NCIT:C45264](http://purl.obolibrary.org/obo/NCIT_C45264) (Cutaneous Chronic Lymphocytic Leukemia), [NCIT:C7217](http://purl.obolibrary.org/obo/NCIT_C7217) (Primary Cutaneous Follicle Center Lymphoma), [NCIT:C45267](http://purl.obolibrary.org/obo/NCIT_C45267) (Cutaneous Lymphomatoid Granulomatosis), [NCIT:C45266](http://purl.obolibrary.org/obo/NCIT_C45266) (Cutaneous Mantle Cell Lymphoma), [NCIT:C45214](http://purl.obolibrary.org/obo/NCIT_C45214) (Primary Cutaneous Intravascular Large B-Cell Lymphoma), [NCIT:C45213](http://purl.obolibrary.org/obo/NCIT_C45213) (Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other), [NCIT:C45216](http://purl.obolibrary.org/obo/NCIT_C45216) (Primary Cutaneous Plasmablastic Lymphoma), [NCIT:C7230](http://purl.obolibrary.org/obo/NCIT_C7230) (Primary Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C45215](http://purl.obolibrary.org/obo/NCIT_C45215) (Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma), [NCIT:C7220](http://purl.obolibrary.org/obo/NCIT_C7220) (Grade 1 Cutaneous Follicular Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38660](http://purl.obolibrary.org/obo/NCIT_C38660) (Neoplastic Large B-Lymphocyte with Pale Cytoplasm))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3866](http://purl.obolibrary.org/obo/NCIT_C3866) (Esophageal Leiomyoma))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38658](http://purl.obolibrary.org/obo/NCIT_C38658) (Transformed Peripheral B-Lymphocyte))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38657](http://purl.obolibrary.org/obo/NCIT_C38657) (Neoplastic Immunoblast-Like B-Lymphocyte))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38656](http://purl.obolibrary.org/obo/NCIT_C38656) (ALK Kinase Overexpression))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38655](http://purl.obolibrary.org/obo/NCIT_C38655) (Bulky Disease))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38650](http://purl.obolibrary.org/obo/NCIT_C38650) (Defective Mu Heavy Chain Present))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38649](http://purl.obolibrary.org/obo/NCIT_C38649) (Vacuolated Plasma Cells in the Bone Marrow))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38648](http://purl.obolibrary.org/obo/NCIT_C38648) (Negative Bone Marrow and Peripheral Blood))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38647](http://purl.obolibrary.org/obo/NCIT_C38647) (Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38646](http://purl.obolibrary.org/obo/NCIT_C38646) (Fried-Egg Appearance of the Bone Marrow))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38645](http://purl.obolibrary.org/obo/NCIT_C38645) (Tartrate Resistant Acid Phosphatase Positive Cells Present))) 38.48%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38644](http://purl.obolibrary.org/obo/NCIT_C38644) (Bone Pain))) 38.48%


